Michael Gao
CEO/Co-founder

SmarterDx utilizes clinical AI to analyze 100% of patient charts, identifying both documented and undocumented diagnoses to enhance hospital revenue integrity. The technology delivers measurable financial benefits, generating an average of $2 million in net new revenue per 10,000 patient discharges while providing a 5:1 return on investment.
Raised to date
$71MRaised to date based on public sources. This may differ from the amount the company actually raised and is based only on what is publicly available on the internet.




Hospitals face increasing challenges in capturing the complete value of care delivered due to missed or undocumented diagnoses in patient charts. This leads to revenue leakage, inaccurate quality metrics, and difficulties in appealing denied claims, impacting the financial health of the institution.
SmarterDx offers a clinical AI platform that analyzes 100% of patient charts to identify both documented and undocumented diagnoses, ensuring comprehensive revenue capture and improved quality metrics. The platform leverages over 2,200 proprietary algorithms designed by physicians to accurately represent the patient journey. SmarterDx integrates directly into existing clinical documentation integrity (CDI) workflows, augmenting the capabilities of existing teams without disrupting their processes. By pinpointing the root cause of denials and generating evidence-backed appeal letters, SmarterDx enables hospitals to recover lost revenue and optimize their reimbursement cycle. The AI solution flags clinical evidence that's missing an optimal associated diagnosis and diagnoses with no associated evidence, which boosts compliance.
SmarterDx primarily targets hospitals and health systems seeking to improve revenue integrity, reduce claim denials, and enhance the accuracy of their clinical documentation.